Article

Stereotactic body RT efficacious in localized PCa

Stereotactic body radiotherapy appears to be an effective treatment option for patients with organ-confined prostate cancer, according to two separate studies presented at the American Association for Radiation Oncology annual meeting in Boston.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!
Related Videos
Medical stethoscope and dollar bills | Image Credit: © Kuzmick - stock.adobe.com
1 expert is featured in this series.
1 expert is featured in this series.
Daniel D. Joyce, MD, MS, answers a question during a Zoom video interview
Related Content
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
July 8th 2025

UK’s MHRA approves nogapendekin alfa inbakicept plus BCG in NMIBC

Benjamin P. Saylor Hannah Clarke
According to the company, the MHRA approval represents the first marketing approval outside the US for NAI.
Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD
June 30th 2025

Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD

Amy M. Pearlman, MD
Pearlman and Parekattil dig deep into novel surgical and non-surgical approaches to chronic orchialgia and pelvic pain.
Zelenectide pevedotin plus pembrolizumab shows promising anti-tumor activity in mUC
July 8th 2025

Zelenectide pevedotin plus pembrolizumab shows promising anti-tumor activity in mUC

Hannah Clarke
The data, collected as part of the phase 1/2 Duravelo-1 trial, showed an objective response rate of 65%.
Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD
June 19th 2025

Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD

Amy M. Pearlman, MD
The conversation covers practical, case-based strategies for counseling MSM patients.
Expanded indication sought for niraparib plus AAP in Europe
July 7th 2025

Expanded indication sought for niraparib plus AAP in Europe

Hannah Clarke
The application is supported by data from the phase 3 AMPLITUDE trial.
Regulatory recap: FDA approvals in urology from the first half of 2025
July 4th 2025

Regulatory recap: FDA approvals in urology from the first half of 2025

Hannah Clarke
Take a look through all the regulatory milestones in urology from the first half of the 2025.
© 2025 MJH Life Sciences

All rights reserved.